Medical Cannabis: Greens Want to Extend the Trial and Speed Up Its Rollout
Published
The Green (Écologiste) deputies have tabled two amendments aimed at changing the framework for medical cannabis in France. Their goal is to extend the ongoing trial and accelerate its nationwide rollout. These proposals still need to be examined before they may be adopted.
Medical cannabis is currently authorised in France as part of a trial. This trial allows certain patients to receive cannabis-based medicines, under medical supervision, to relieve certain pain or symptoms. For the Greens, the current period is not long enough to fully evaluate this scheme. Extending the trial would, in their view, make it possible to gather more data on its effectiveness and safety.
The second amendment concerns the generalisation of the scheme. The Greens want medical cannabis to be available to a larger number of patients in the coming years. They believe that broader access would prevent situations where patients have to wait a long time or turn to unregulated solutions. These proposals nevertheless raise questions about funding, the training of doctors and the control of production.
For now, the decision rests with Parliament, which must discuss these amendments. If they are approved, these measures could change French patients' access to medical cannabis in the coming months. The debate is expected to continue in the coming weeks.
Sources: Newsweed
More France news
- Maxime Pavageau, 29, wins France's best young wine seller title
- A New, Highly Promising Concrete
- Paris and Île-de-France: Immersive Exhibitions to Experience Art Differently
- France 3 broadcasts a documentary on the history of the Téléthon, narrated by Zazie
- ChatGPT launches business profiles with mention and click statistics
- Trail: France Outdoor Seeks to Frame Environmental Restrictions
- A Roanne company bets on knitwear made in France
- Sport: Major Win for the Brûleurs de Loups and Six Internationals Absent for FC Annecy